Fairvalue-Calculator Fairvalue-Calculator
EN DE

Holobeam, Inc (HOOB) Fair Value & Analysis

Real Estate · US · Market cap $3.0M

Price$26.00
Fair Value$59.44
Upside+128.6%
Quality89/100
Evidence: Medium Range $33.74 – $85.73

Fair value as of: Jun 26, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Holobeam, Inc (HOOB) currently trades at $26.00, while our model-based Fair Value estimate is $59.44 — implying the stock looks roughly 128.6% undervalued today. We read business quality at 89/100 (high quality), in the Real Estate sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

Holobeam, Inc. engages in the rental and development of real estate properties in New Jersey. As of September 30, 2006, it leased two buildings for retail use. The company was founded in 1967 and is headquartered in Ho-Ho-Kus, New Jersey.

Open the full interactive analysis →

Similar stocks

Frequently asked questions

Is Holobeam, Inc (HOOB) undervalued?
As of Jun 26, 2026, our model estimates a fair value of $59.44 versus a price of $26.00 — about +129% (undervalued). Model-based estimate, not financial advice.
What is the fair value of HOOB?
Our 21-model fair value for Holobeam, Inc is $59.44 (as of Jun 26, 2026), built from audited fundamentals. The current price is $26.00.
What is the quality score of HOOB?
Holobeam, Inc has a Quality Score of 89/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.